Forget Hexo (TSX:HEXO) Stock! This High-Yield Dividend Stock Is a Sure Winner

Hexo’s stock price has tumbled about 80% from its high. Buying cannabis stocks is like going on a roller-coaster ride with your eyes closed — you don’t know when you’ll fall or be upside down in a loop. For more certain returns, invest in Brookfield Property Partners (TSX:BPY.UN)(NASDAQ:BPY). Price action Hexo investors probably don’t care about fundamentals, because the company is…

Read More

2 Massive Growth Catalysts for the Canadian Cannabis Sector

Investors in the Canadian cannabis space have undoubtedly been hit hard of late. The Exchange-Traded Fund (ETF) tracking the sector, Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ) has dipped to near-record lows of late on headwinds related to profitability across the sector, a number of recalls, and issues surrounding the black market and the willingness of Canadians to pay full pop…

Read More

Why Canopy Growth (TSX:WEED) Stock Can Get Back All-Time Highs in 2020

The second phase of cannabis legalization in Canada, often called “Cannabis 2.0,” has reinvigorated many stocks in the sector over the last few months. Cannabis ETFs have gained momentum after being pummeled for most of 2019. Horizons Marijuana Life Sciences ETF has increased 7.6% over the past month as of close on January 16. Canopy Growth remains the biggest Canadian cannabis player. Shares…

Read More

Canopy Growth (TSX:WEED) Stock Price: Should You Buy the Bounce?

Marijuana stocks have picked up a new tailwind in recent days, and investors are wondering if this could be the start of another big rally for share prices of the cannabis producers. Cannabis 2.0 Canopy Growth (TSX:WEED)(NYSE:CGC) is a leader in the Canadian and global marijuana industry. The stock has traded as high as $70 per share in the past…

Read More

Why Did Supreme Cannabis (TSX:FIRE) Stock Drop 70%?

Supreme Cannabis Company Inc (TSX:FIRE) was once on top of the world. At the start of 2018, it was a billion dollar company. Investors were rushing in to take advantage of the emerging cannabis boom. Then, everything changed. With a current valuation of just $195 million, Supreme Cannabis risks falling off the radar completely. The rapid deterioration of shareholder value…

Read More

Revealed: This Pot Stock Could Soon Pay a Dividend

One of the biggest stories in Canadian business over the latter half of 2019 was the massive implosion of Canada’s marijuana sector. Leading pot stocks fell as much as 50-75%. A number of factors contributed to the fall, but mostly it came down to sentiment. Investors went from being incredibly bullish on the future of legal marijuana in Canada to…

Read More

Is HEXO Stock a Buy After Restated Earnings?

Cannabis producer HEXO’s (TSX:HEXO)(NYSE:HEXO) stock has been on a strong rebound lately since the start of the new year and the share price closed nearly 16% higher on Wednesday as the pot industry received an Organigram Holdings powered valuation boost. The company recently filed restated financial reports for its fiscal year which ended July 31, 2019 as well as amended…

Read More

Should You Stay Away From Pot Stocks in 2020?

After booming for more than three years, the marijuana bubble started to burst in 2018 following legalization. The downhill move continued in 2019. Marijuana companies failed to meet expectations on revenue, as they had to face oversupply problems. It looks like the demand for cannabis was overestimated, and the hype has faded.  With the sharp decline in stock prices, we…

Read More

3 Top Stocks to Maximize Your RRSP!

Canada has a number of excellent retirement savings options, and while the oft-touted Tax-Free Savings Account (TFSA) is typically the first savings mechanism used by investors to grow tax-free income in retirement, using a Registered Retirement Savings Plan (RRSP) effectively can be an excellent way to stash away money (and take important tax deductions!) on an annual basis and watch…

Read More

Should You Buy Organigram (TSX:OGI) Stock Today?

The fact that cannabis producer Organigram Holdings (TSX:OGI)(NASDAQ:OGI) delivered a 102% year-over-year net revenue growth for the recently reported first quarter of fiscal 2020 doesn’t move me as much as a 54% sequential sales increase over a recent previous quarter does. The year-over-year comparison pits one quarter with very little recreational pot sales generated in just one full month and…

Read More